{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:51:50Z","timestamp":1791409910209,"version":"4.3.3"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004410","name":"Scientific and Technological Research Council of Turkey","doi-asserted-by":"publisher","award":["214Z098"],"award-info":[{"award-number":["214Z098"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bioorg.2026.110430","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T22:40:06Z","timestamp":1787438406000},"page":"110430","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Molecular insights into the antineoplastic mechanisms of mono- and bimetallic ruthenium(II) arene diamine complexes: a comprehensive evaluation"],"prefix":"10.1016","volume":"181","author":[{"given":"Serdar Bat\u0131kan","family":"Kavukcu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hafize Seda","family":"Vatansever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feyzan","family":"\u00d6zdal-Kurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Korkmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burcu","family":"Erbaykent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilal Kabaday\u0131","family":"Ensario\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayati","family":"T\u00fcrkmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.110430_bb0005","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/222385a0","article-title":"Platinum compounds: a new class of potent antitumour agents","volume":"222","author":"Rosenberg","year":"1969","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2026.110430_bb0010","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin in cancer therapy: molecular mechanisms of action","volume":"740","author":"Dasari","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.110430_bb0015","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrd1691","article-title":"Cellular processing of platinum anticancer drugs","volume":"4","author":"Wang","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2026.110430_bb0020","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1021\/cr980420v","article-title":"Current status of platinum-based antitumor drugs","volume":"99","author":"Wong","year":"1999","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioorg.2026.110430_bb0025","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/S0026-895X(24)12463-7","article-title":"Oxaliplatin-induced damage of cellular DNA","volume":"58","author":"Woynarowski","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.110430_bb0030","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ejmech.2011.12.017","article-title":"Synthesis, antiproliferative activity and estrogen receptor \u03b1 affinity of novel estradiol-linked platinum(II) complex analogs to carboplatin and oxaliplatin","volume":"48","author":"Saha","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110430_bb0035","doi-asserted-by":"crossref","first-page":"6645","DOI":"10.1039\/C8DT00838H","article-title":"The side effects of platinum-based chemotherapy drugs: a review for chemists","volume":"47","author":"Oun","year":"2018","journal-title":"Dalton Trans."},{"key":"10.1016\/j.bioorg.2026.110430_bb0040","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.cbpa.2012.01.013","article-title":"The potential of organometallic complexes in medicinal chemistry","volume":"16","author":"Gasser","year":"2012","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.bioorg.2026.110430_bb0045","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1021\/cr9804238","article-title":"Non-platinum chemotherapeutic Metallopharmaceuticals","volume":"99","author":"Clarke","year":"1999","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioorg.2026.110430_bb0050","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0898-8838(08)60271-8","article-title":"Medicinal inorganic chemistry","volume":"49","author":"Guo","year":"1999","journal-title":"Adv. Inorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110430_bb0055","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1039\/B916860P","article-title":"Arene ruthenium complexes as anticancer agents","volume":"39","author":"S\u00fcss-Fink","year":"2010","journal-title":"Dalton Trans."},{"key":"10.1016\/j.bioorg.2026.110430_bb0060","doi-asserted-by":"crossref","first-page":"4764","DOI":"10.1039\/b508531b","article-title":"Organometallic chemistry, biology and medicine: ruthenium arene anticancer complexes","author":"Yan","year":"2005","journal-title":"Chem. Commun."},{"key":"10.1016\/j.bioorg.2026.110430_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2023.215169","article-title":"An overview of advancement of organoruthenium(II) complexes as prospective anticancer agents","volume":"487","author":"Bashir","year":"2023","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.bioorg.2026.110430_bb0070","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0010-8545(02)00312-0","article-title":"Ruthenium metallopharmaceuticals","volume":"232","author":"Clarke","year":"2003","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.bioorg.2026.110430_bb0075","first-page":"231","article-title":"Oncological implications of the chemistry of ruthenium ions","volume":"11","author":"Clarke","year":"1980","journal-title":"Met. Ions Biol. Syst."},{"key":"10.1016\/j.bioorg.2026.110430_bb0080","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1595\/003214001X4526269","article-title":"Ruthenium in medicine: current clinical uses and future prospects","volume":"45","author":"Allardyce","year":"2001","journal-title":"Platin. Met. Rev."},{"key":"10.1016\/j.bioorg.2026.110430_bb0085","doi-asserted-by":"crossref","first-page":"5805","DOI":"10.1021\/acs.jmedchem.7b01689","article-title":"Ru(II) compounds: next-generation anticancer Metallotherapeutics?","volume":"61","author":"Thota","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110430_bb0090","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.3390\/molecules24101995","article-title":"NAMI-A and KP1019\/1339 two iconic ruthenium anticancer drug candidates face-to-face: a case story in medicinal inorganic chemistry","volume":"24","author":"Alessio","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.110430_bb0095","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ccr.2018.07.012","article-title":"Ruthenium coordination compounds of biological and biomedical significance. DNA binding agents","volume":"376","author":"Brabec","year":"2018","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.bioorg.2026.110430_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2019.07.008","article-title":"Chemistry and reactivity of ruthenium(II) complexes: DNA\/protein binding mode and anticancer activity are related to the complex structure","volume":"398","author":"Rilak Simovi\u0107","year":"2019","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.bioorg.2026.110430_bb0105","doi-asserted-by":"crossref","first-page":"5771","DOI":"10.1039\/C7CS00195A","article-title":"The development of anticancer ruthenium(II) complexes: from single molecule compounds to nanomaterials","volume":"46","author":"Zeng","year":"2017","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.bioorg.2026.110430_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2021.214403","article-title":"Piano stool Ru(II)-arene complexes having three monodentate legs: a comprehensive review on their development as anticancer therapeutics over the past decade","volume":"459","author":"Swaminathan","year":"2022","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.bioorg.2026.110430_bb0115","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jinorgbio.2009.10.005","article-title":"In vivo tumour and metastasis reduction and in vitro effects on invasion assays of the ruthenium RM175 and osmium AFAP51 organometallics in the mammary cancer model","volume":"104","author":"Bergamo","year":"2010","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.bioorg.2026.110430_bb0120","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1039\/C2DT32091F","article-title":"Competition between glutathione and DNA oligonucleotides for ruthenium(II) arene anticancer complexes","volume":"42","author":"Wang","year":"2013","journal-title":"Dalton Trans."},{"key":"10.1016\/j.bioorg.2026.110430_bb0125","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1021\/jm050015d","article-title":"In vitro and in vivo evaluation of ruthenium(II)-arene PTA complexes","volume":"48","author":"Scolaro","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110430_bb0130","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1039\/D1MD00220A","article-title":"Ruthenium(II)-arene complexes as anti-metastatic agents, and related techniques","volume":"13","author":"Sonkar","year":"2022","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110430_bb0135","doi-asserted-by":"crossref","first-page":"7817","DOI":"10.1039\/c0dt01816c","article-title":"Ruthenium anticancer compounds: myths and realities of the mechanisms of action","volume":"40","author":"Bergamo","year":"2011","journal-title":"Dalton Trans."},{"key":"10.1016\/j.bioorg.2026.110430_bb0140","doi-asserted-by":"crossref","first-page":"5375","DOI":"10.2147\/DDDT.S275007","article-title":"Ruthenium complexes as anticancer agents: a brief history and perspectives","volume":"14","author":"Lee","year":"2020","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.bioorg.2026.110430_bb0145","doi-asserted-by":"crossref","unstructured":"S.B. Kavukcu, H.S. Vatansever, S. Ilhan, H. T\u00fcrkmen, Naphthyl-substituted ruthenium(II)-arene complexes: exploring the impact of binding modes on cytotoxicity in cancer and normal cell lines, Bioinorg. Chem. Appl. 2025 (2025) 5556956.","DOI":"10.1155\/bca\/5556956"},{"key":"10.1016\/j.bioorg.2026.110430_bb0150","doi-asserted-by":"crossref","first-page":"6858","DOI":"10.1021\/jm060596m","article-title":"Structure-activity relationships for cytotoxic ruthenium(II) arene complexes containing N,N-, N,O-, and O,O-chelating ligands","volume":"49","author":"Habtemariam","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110430_bb0155","doi-asserted-by":"crossref","first-page":"5771","DOI":"10.1039\/C7CS00195A","article-title":"The development of anticancer ruthenium(ii) complexes: from single molecule compounds to nanomaterials","volume":"46","author":"Zeng","year":"2017","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.bioorg.2026.110430_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103793","article-title":"Synthesis and cytotoxic activities of organometallic Ru(II) diamine complexes","volume":"99","author":"Kavukcu","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110430_bb0165","series-title":"Apoptotic properties of Rutheinum complexes on different type of Cancer cell lines","first-page":"1593","author":"Vatansever","year":"2018"},{"key":"10.1016\/j.bioorg.2026.110430_bb0170","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1039\/C3RA44131H","article-title":"Multifaceted half-sandwich arene-ruthenium complexes: interactions with biomolecules, photoactivation, and multinuclearity approach","volume":"4","author":"Singh","year":"2014","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2026.110430_bb0175","first-page":"32174","article-title":"A ruthenium(II) arene complex bearing a 1,10-phenanthroline derivative inhibits tumor migration and invasion through the ROS-mediated signaling pathway","volume":"6","author":"Chen","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.110430_bb0180","first-page":"8891","article-title":"Exploring the potential of metallodrugs as chemotherapeutics for triple negative breast Cancer","volume":"2021","author":"Nayeem","year":"2021","journal-title":"Eur. J. Inorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110430_bb0185","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejmech.2016.06.020","article-title":"The induction of apoptosis in HepG-2 cells by ruthenium(II) complexes through an intrinsic ROS-mediated mitochondrial dysfunction pathway","volume":"122","author":"Zeng","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110430_bb0190","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1038\/sj.bjc.6600290","article-title":"In vitro and in vivo activity and cross resistance profiles of novel ruthenium (II) organometallic arene complexes","volume":"86","author":"Aird","year":"2002","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bioorg.2026.110430_bb0195","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1039\/c3mt20270d","article-title":"The induction of mitochondria-mediated apoptosis in cancer cells by ruthenium(II) asymmetric complexes","volume":"5","author":"Qian","year":"2013","journal-title":"Metallomics"},{"key":"10.1016\/j.bioorg.2026.110430_bb0200","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1021\/jm010051m","article-title":"Inhibition of cancer cell growth by ruthenium(II) arene complexes","volume":"44","author":"Morris","year":"2001","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110430_bb0205","first-page":"693","article-title":"Bimetallic ruthenium(II) arene complexes as potent anticancer agents: synthesis, characterization, and biological evaluation","volume":"10","author":"Tan","year":"2015","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2026.110430_bb0210","doi-asserted-by":"crossref","first-page":"6923","DOI":"10.1021\/jm1004804","article-title":"Development of bimetallic titanocene-ruthenium-arene complexes as anticancer agents: relationships between structural and biological properties","volume":"53","author":"Pelletier","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110430_bb0215","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jorganchem.2013.09.016","article-title":"Opening the lid on piano-stool complexes: an account of ruthenium(II)\u2013arene complexes with medicinal applications","volume":"751","author":"Nazarov","year":"2014","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.bioorg.2026.110430_bb0220","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1039\/b601840h","article-title":"Metal-based antitumour drugs in the post genomic era","author":"Dyson","year":"2006","journal-title":"Dalton Trans."},{"key":"10.1016\/j.bioorg.2026.110430_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.inoche.2025.115999","article-title":"The determination of the potential anticancer effects of ruthenium (Ru) arene complexes in PC-3, Du-145, and LNCaP prostate cancer cell lines","volume":"184","author":"\u00d6zcan","year":"2026","journal-title":"Inorg. Chem. Commun."},{"key":"10.1016\/j.bioorg.2026.110430_bb0230","doi-asserted-by":"crossref","DOI":"10.1002\/aoc.7363","volume":"38","author":"Kavukcu","year":"2024","journal-title":"Appl. Organomet. Chem."},{"key":"10.1016\/j.bioorg.2026.110430_bb0240","doi-asserted-by":"crossref","first-page":"37549","DOI":"10.1021\/acsomega.3c05898","article-title":"Cell death mechanism of organometallic ruthenium (II) and iridium (III) arene complexes on HepG2 and Vero cells","volume":"8","author":"Kavukcu","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.bioorg.2026.110430_bb0245","doi-asserted-by":"crossref","first-page":"111","DOI":"10.18466\/cbayarfbe.1665318","article-title":"Computational ADME analysis of a Schiff base and its ruthenium complex: implications for medicinal chemistry","volume":"21","author":"Kavukcu","year":"2025","journal-title":"Celal Bayar \u00dcniversitesi Fen Bilimleri Dergisi"},{"key":"10.1016\/j.bioorg.2026.110430_bb0250","doi-asserted-by":"crossref","first-page":"5858","DOI":"10.1074\/jbc.273.10.5858","article-title":"DNA double-strand breaks induce histone H2AX phosphorylation on serine 139","volume":"273","author":"Rogakou","year":"1998","journal-title":"J. Biol. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826009661?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826009661?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:14:41Z","timestamp":1791407681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826009661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":49,"alternative-id":["S0045206826009661"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110430","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular insights into the antineoplastic mechanisms of mono- and bimetallic ruthenium(II) arene diamine complexes: a comprehensive evaluation","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110430","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110430"}}